Skip to Main Content
The student news site of The Harker School.

Harker Aquila

The student news site of The Harker School.

Harker Aquila

The student news site of The Harker School.

Harker Aquila

California State Senator Scott Wiener introduces California Senate Bill 866 (SB 866), which would allow individuals 12 years old and older to receive vaccinations without parental approval, on Jan. 21 at a press conference in San Francisco. “I think we have a shot for getting it passed,” Weiner said. “It's not guaranteed, the California legislative process is very complicated."

State legislation proposed to expand vaccination age of consent

by Lucy Ge, Co-Managing Editor February 7, 2022

California State Senator Scott Wiener (D-CA) introduced California Senate Bill 866 (SB 866), which would allow individuals 12 years old and older to receive vaccinations without parental approval, on Jan....

A pharmacist prepares a Pfizer booster shot on January 15 at the Los Gatos Safeway Pharmacy. The FDA approved of administration of the booster to children aged 12 to 15 on January 3.

FDA authorizes Pfizer COVID-19 booster shot for individuals aged 12 to 15

by Lavanya Subramanian and Tiffany Chang January 15, 2022

The Food and Drug Administration (FDA) expanded the availability of the Pfizer-BioNTech COVID-19 booster vaccine to children between ages 12 and 15 on Jan. 3.  This authorization followed after the...

Senior Sachi Bajaj received her vaccine today. She and her family qualified to receive the vaccine as caregivers for her grandparents, who are at high risk of contracting the coronavirus.

Harker staff and students receive COVID-19 vaccinations, more scheduled this month

by Lucy Ge, Winged Post News Editor March 1, 2021

With upper school faculty and students beginning to receive their COVID-19 vaccines, more Harker staff are set to be vaccinated in Phase 1B of California’s vaccination plan.  All education workers,...

The US Food and Drug Association gave full approval to the Pfizer-BioNTech COVID-19 vaccine on Monday for individuals older than sixteen years. Previously, the treatment was only administered under an emergency use authorization (EUA), which was granted in December 2020.

3 COVID-19 vaccines move forward after promising Phase 3 clinical trial data

by Mark Hu and Sabrina Zhu December 2, 2020

Biotechnology companies Pfizer, Moderna and AstraZeneca released first interim analysis reports from Phase 3 trials of their respective COVID-19 vaccines, all within the past month. The vaccines have efficacy...

Load More Stories